Plasma exchange in the intensive care unit: a narrative review
Abstract In this narrative review, we discuss the relevant issues of therapeutic plasma exchange (TPE) in critically ill patients. For many conditions, the optimal indication, device type, frequency, duration, type of replacement fluid and criteria for stopping TPE are uncertain. TPE is a potentially lifesaving but also invasive procedure with risk of adverse events and complications and requires close monitoring by experienced teams. In the intensive care unit (ICU), the indications for TPE can be divided into (1) absolute, well-established, and evidence-based, for which TPE is recognized as first-line therapy, (2) relative, for which TPE is a recognized second-line treatment (alone or combined) and (3) rescue therapy, where TPE is used with a limited or theoretical evidence base. New indications are emerging and ongoing knowledge gaps, notably regarding the use of TPE during critical illness, support the establishment of a TPE registry dedicated to intensive care medicine..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:48 |
|---|---|
| Enthalten in: |
Intensive care medicine - 48(2022), 10 vom: 12. Aug., Seite 1382-1396 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bauer, Philippe R. [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
Intensive care units |
|---|
| Anmerkungen: |
© Springer-Verlag GmbH Germany, part of Springer Nature 2022 |
|---|
| doi: |
10.1007/s00134-022-06793-z |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR048072001 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR048072001 | ||
| 003 | DE-627 | ||
| 005 | 20230519100244.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220913s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00134-022-06793-z |2 doi | |
| 035 | |a (DE-627)SPR048072001 | ||
| 035 | |a (SPR)s00134-022-06793-z-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bauer, Philippe R. |e verfasserin |0 (orcid)0000-0001-8429-3581 |4 aut | |
| 245 | 1 | 0 | |a Plasma exchange in the intensive care unit: a narrative review |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © Springer-Verlag GmbH Germany, part of Springer Nature 2022 | ||
| 520 | |a Abstract In this narrative review, we discuss the relevant issues of therapeutic plasma exchange (TPE) in critically ill patients. For many conditions, the optimal indication, device type, frequency, duration, type of replacement fluid and criteria for stopping TPE are uncertain. TPE is a potentially lifesaving but also invasive procedure with risk of adverse events and complications and requires close monitoring by experienced teams. In the intensive care unit (ICU), the indications for TPE can be divided into (1) absolute, well-established, and evidence-based, for which TPE is recognized as first-line therapy, (2) relative, for which TPE is a recognized second-line treatment (alone or combined) and (3) rescue therapy, where TPE is used with a limited or theoretical evidence base. New indications are emerging and ongoing knowledge gaps, notably regarding the use of TPE during critical illness, support the establishment of a TPE registry dedicated to intensive care medicine. | ||
| 650 | 4 | |a Plasma exchange |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Plasmapheresis |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Intensive care units |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a State-of-the-art review |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Patient care team |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Ostermann, Marlies |4 aut | |
| 700 | 1 | |a Russell, Lene |4 aut | |
| 700 | 1 | |a Robba, Chiara |4 aut | |
| 700 | 1 | |a David, Sascha |4 aut | |
| 700 | 1 | |a Ferreyro, Bruno L. |4 aut | |
| 700 | 1 | |a Cid, Joan |4 aut | |
| 700 | 1 | |a Castro, Pedro |4 aut | |
| 700 | 1 | |a Juffermans, Nicole P. |4 aut | |
| 700 | 1 | |a Montini, Luca |4 aut | |
| 700 | 1 | |a Pirani, Tasneem |4 aut | |
| 700 | 1 | |a Van De Louw, Andry |4 aut | |
| 700 | 1 | |a Nielsen, Nathan |4 aut | |
| 700 | 1 | |a Wendon, Julia |4 aut | |
| 700 | 1 | |a Brignier, Anne C. |4 aut | |
| 700 | 1 | |a Schetz, Miet |4 aut | |
| 700 | 1 | |a Kielstein, Jan T. |4 aut | |
| 700 | 1 | |a Winters, Jeffrey L. |4 aut | |
| 700 | 1 | |a Azoulay, Elie |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Intensive care medicine |d Berlin : Springer, 1975 |g 48(2022), 10 vom: 12. Aug., Seite 1382-1396 |w (DE-627)SPR001167375 |w (DE-600)1459201-0 |x 1432-1238 |7 nnns |
| 773 | 1 | 8 | |g volume:48 |g year:2022 |g number:10 |g day:12 |g month:08 |g pages:1382-1396 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s00134-022-06793-z |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 48 |j 2022 |e 10 |b 12 |c 08 |h 1382-1396 | ||